Graafsma et al used a scale to describe the impact of anticoagulant-related bleeding on a patient. The authors are from the University of Amsterdam and University Hospital Leiden in the Netherlands.
Parameters:
(1) global impact
(2) effect on activities of daily living (impairment)
(3) requirement for care
|
Overall Impact |
Impairment |
Requirement for Care |
Grade |
|
none |
none (normal) |
none |
1 |
|
minimum (minor) |
none (normal) |
none |
2 |
|
mild (some) |
mild impairment but does not interfere with activities of daily living |
minor |
3 |
|
moderate |
restricted, some impact on activities of daily living |
may require some attention as outpatient |
4 |
|
moderate to severe |
no longer independent |
requires medical attention but not continuous |
5 |
|
severe |
marked impairment or death |
continuous 24 hour attention |
6 |
If there was inadequate information to determine the impact, then the patient was Grade 7.
Purpose: To grade the impact of anticoagulant-related bleeding using the scale of Graafsma et al.
Specialty: Sports Medicine & Rehabilitation, Hematology Oncology
Objective: response to therapy, adverse effects
ICD-10: I20-I25, I60-I69, I70, I71, I72, I73, I74, T88.7,
